Relative factors by segment
Each segment is a separate regression; the factor is added to the beneficiary's demographic factors and other categories, then normalized and reduced by the coding intensity adjustment before it meets the plan's base rate. A factor of 1.000 equals the expected cost of an average beneficiary.
| Segment | Model code | Relative factor |
|---|---|---|
| Community, non-dual, aged | CNA_HCC20 | 1.136 |
| Community, non-dual, disabled | CND_HCC20 | 0.978 |
| Community, full-benefit dual, aged | CFA_HCC20 | 1.166 |
| Community, full-benefit dual, disabled | CFD_HCC20 | 1.173 |
| Community, partial-benefit dual, aged | CPA_HCC20 | 1.214 |
| Community, partial-benefit dual, disabled | CPD_HCC20 | 1.067 |
| Long-term institutional | INS_HCC20 | 0.672 |
Hierarchy
Hierarchical condition categories pay only the most severe manifestation of a disease. When HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also documented for the same beneficiary, HCC 20 is dropped from the score. When HCC 20 is present it drops HCC 21 (Lymphoma and Other Cancers), HCC 22 (Bladder, Colorectal, and Other Cancers), HCC 23 (Prostate, Breast, and Other Cancers and Tumors), so documenting the less severe condition alongside it adds nothing to payment but still matters for the clinical record.
ICD-10-CM codes that map to HCC 20
233 codes map to this category in the PY2027 initial mapping, concentrated in the C84 (55), C83 (45), C34 (16), C72 (14), C93 (12), C71 (10) code families. Descriptions are the CMS mapping descriptions for the FY2026 code set; a code that is deleted or split in the October code update stays valid for dates of service before the change.
| ICD-10-CM | Description |
|---|---|
| C153 | Malignant neoplasm of upper third of esophagus |
| C154 | Malignant neoplasm of middle third of esophagus |
| C155 | Malignant neoplasm of lower third of esophagus |
| C158 | Malignant neoplasm of overlapping sites of esophagus |
| C159 | Malignant neoplasm of esophagus, unspecified |
| C160 | Malignant neoplasm of cardia |
| C161 | Malignant neoplasm of fundus of stomach |
| C162 | Malignant neoplasm of body of stomach |
| C163 | Malignant neoplasm of pyloric antrum |
| C164 | Malignant neoplasm of pylorus |
| C165 | Malignant neoplasm of lesser curvature of stomach, unspecified |
| C166 | Malignant neoplasm of greater curvature of stomach, unspecified |
| C168 | Malignant neoplasm of overlapping sites of stomach |
| C169 | Malignant neoplasm of stomach, unspecified |
| C170 | Malignant neoplasm of duodenum |
| C171 | Malignant neoplasm of jejunum |
| C172 | Malignant neoplasm of ileum |
| C173 | Meckel's diverticulum, malignant |
| C178 | Malignant neoplasm of overlapping sites of small intestine |
| C179 | Malignant neoplasm of small intestine, unspecified |
| C220 | Liver cell carcinoma |
| C221 | Intrahepatic bile duct carcinoma |
| C222 | Hepatoblastoma |
| C223 | Angiosarcoma of liver |
| C224 | Other sarcomas of liver |
| C227 | Other specified carcinomas of liver |
| C228 | Malignant neoplasm of liver, primary, unspecified as to type |
| C229 | Malignant neoplasm of liver, not specified as primary or secondary |
| C23 | Malignant neoplasm of gallbladder |
| C240 | Malignant neoplasm of extrahepatic bile duct |
| C241 | Malignant neoplasm of ampulla of Vater |
| C248 | Malignant neoplasm of overlapping sites of biliary tract |
| C249 | Malignant neoplasm of biliary tract, unspecified |
| C250 | Malignant neoplasm of head of pancreas |
| C251 | Malignant neoplasm of body of pancreas |
| C252 | Malignant neoplasm of tail of pancreas |
| C253 | Malignant neoplasm of pancreatic duct |
| C254 | Malignant neoplasm of endocrine pancreas |
| C257 | Malignant neoplasm of other parts of pancreas |
| C258 | Malignant neoplasm of overlapping sites of pancreas |
| C259 | Malignant neoplasm of pancreas, unspecified |
| C33 | Malignant neoplasm of trachea |
| C3400 | Malignant neoplasm of unspecified main bronchus |
| C3401 | Malignant neoplasm of right main bronchus |
| C3402 | Malignant neoplasm of left main bronchus |
| C3410 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C3411 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C3412 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C342 | Malignant neoplasm of middle lobe, bronchus or lung |
| C3430 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C3431 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C3432 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C3480 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C3481 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C3482 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C3490 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C3491 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C3492 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C380 | Malignant neoplasm of heart |
| C384 | Malignant neoplasm of pleura |
| C480 | Malignant neoplasm of retroperitoneum |
| C481 | Malignant neoplasm of specified parts of peritoneum |
| C482 | Malignant neoplasm of peritoneum, unspecified |
| C488 | Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
| C700 | Malignant neoplasm of cerebral meninges |
| C701 | Malignant neoplasm of spinal meninges |
| C709 | Malignant neoplasm of meninges, unspecified |
| C710 | Malignant neoplasm of cerebrum, except lobes and ventricles |
| C711 | Malignant neoplasm of frontal lobe |
| C712 | Malignant neoplasm of temporal lobe |
| C713 | Malignant neoplasm of parietal lobe |
| C714 | Malignant neoplasm of occipital lobe |
| C715 | Malignant neoplasm of cerebral ventricle |
| C716 | Malignant neoplasm of cerebellum |
| C717 | Malignant neoplasm of brain stem |
| C718 | Malignant neoplasm of overlapping sites of brain |
| C719 | Malignant neoplasm of brain, unspecified |
| C720 | Malignant neoplasm of spinal cord |
| C721 | Malignant neoplasm of cauda equina |
| C7220 | Malignant neoplasm of unspecified olfactory nerve |
| C7221 | Malignant neoplasm of right olfactory nerve |
| C7222 | Malignant neoplasm of left olfactory nerve |
| C7230 | Malignant neoplasm of unspecified optic nerve |
| C7231 | Malignant neoplasm of right optic nerve |
| C7232 | Malignant neoplasm of left optic nerve |
| C7240 | Malignant neoplasm of unspecified acoustic nerve |
| C7241 | Malignant neoplasm of right acoustic nerve |
| C7242 | Malignant neoplasm of left acoustic nerve |
| C7250 | Malignant neoplasm of unspecified cranial nerve |
| C7259 | Malignant neoplasm of other cranial nerves |
| C729 | Malignant neoplasm of central nervous system, unspecified |
| C751 | Malignant neoplasm of pituitary gland |
| C752 | Malignant neoplasm of craniopharyngeal duct |
| C753 | Malignant neoplasm of pineal gland |
| C773 | Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes |
| C8310 | Mantle cell lymphoma, unspecified site |
| C8311 | Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C8312 | Mantle cell lymphoma, intrathoracic lymph nodes |
| C8313 | Mantle cell lymphoma, intra-abdominal lymph nodes |
| C8314 | Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C8315 | Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C8316 | Mantle cell lymphoma, intrapelvic lymph nodes |
| C8317 | Mantle cell lymphoma, spleen |
| C8318 | Mantle cell lymphoma, lymph nodes of multiple sites |
| C8319 | Mantle cell lymphoma, extranodal and solid organ sites |
| C831A | Mantle cell lymphoma, in remission |
| C8330 | Diffuse large B-cell lymphoma, unspecified site |
| C8331 | Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C8332 | Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C8333 | Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C8334 | Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C8335 | Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C8336 | Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C8337 | Diffuse large B-cell lymphoma, spleen |
| C8338 | Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83390 | Primary central nervous system lymphoma |
| C83398 | Diffuse large B-cell lymphoma of other extranodal and solid organ sites |
| C833A | Diffuse large B-cell lymphoma, in remission |
| C8350 | Lymphoblastic (diffuse) lymphoma, unspecified site |
| C8351 | Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C8352 | Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C8353 | Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C8354 | Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C8355 | Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C8356 | Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C8357 | Lymphoblastic (diffuse) lymphoma, spleen |
| C8358 | Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C8359 | Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C835A | Lymphoblastic (diffuse) lymphoma, in remission |
| C8370 | Burkitt lymphoma, unspecified site |
| C8371 | Burkitt lymphoma, lymph nodes of head, face, and neck |
| C8372 | Burkitt lymphoma, intrathoracic lymph nodes |
| C8373 | Burkitt lymphoma, intra-abdominal lymph nodes |
| C8374 | Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C8375 | Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C8376 | Burkitt lymphoma, intrapelvic lymph nodes |
| C8377 | Burkitt lymphoma, spleen |
| C8378 | Burkitt lymphoma, lymph nodes of multiple sites |
| C8379 | Burkitt lymphoma, extranodal and solid organ sites |
| C837A | Burkitt lymphoma, in remission |
| C8400 | Mycosis fungoides, unspecified site |
| C8401 | Mycosis fungoides, lymph nodes of head, face, and neck |
| C8402 | Mycosis fungoides, intrathoracic lymph nodes |
| C8403 | Mycosis fungoides, intra-abdominal lymph nodes |
| C8404 | Mycosis fungoides, lymph nodes of axilla and upper limb |
| C8405 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C8406 | Mycosis fungoides, intrapelvic lymph nodes |
| C8407 | Mycosis fungoides, spleen |
| C8408 | Mycosis fungoides, lymph nodes of multiple sites |
| C8409 | Mycosis fungoides, extranodal and solid organ sites |
| C840A | Mycosis fungoides, in remission |
| C8460 | Anaplastic large cell lymphoma, ALK-positive, unspecified site |
| C8461 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck |
| C8462 | Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes |
| C8463 | Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes |
| C8464 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb |
| C8465 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb |
| C8466 | Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes |
| C8467 | Anaplastic large cell lymphoma, ALK-positive, spleen |
| C8468 | Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites |
| C8469 | Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites |
| C846A | Anaplastic large cell lymphoma, ALK-positive, in remission |
| C8490 | Mature T/NK-cell lymphomas, unspecified, unspecified site |
| C8491 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck |
| C8492 | Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes |
| C8493 | Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes |
| C8494 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb |
| C8495 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb |
| C8496 | Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes |
| C8497 | Mature T/NK-cell lymphomas, unspecified, spleen |
| C8498 | Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites |
| C8499 | Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites |
| C849A | Mature T/NK-cell lymphomas, unspecified, in remission |
| C84A0 | Cutaneous T-cell lymphoma, unspecified, unspecified site |
| C84A1 | Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84A2 | Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84A3 | Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84A4 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84A5 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84A6 | Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84A7 | Cutaneous T-cell lymphoma, unspecified, spleen |
| C84A8 | Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84A9 | Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites |
| C84AA | Cutaneous T-cell lymphoma, unspecified, in remission |
| C84Z0 | Other mature T/NK-cell lymphomas, unspecified site |
| C84Z1 | Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck |
| C84Z2 | Other mature T/NK-cell lymphomas, intrathoracic lymph nodes |
| C84Z3 | Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes |
| C84Z4 | Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb |
| C84Z5 | Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb |
| C84Z6 | Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C84Z7 | Other mature T/NK-cell lymphomas, spleen |
| C84Z8 | Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C84Z9 | Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
| C84ZA | Other mature T/NK-cell lymphomas, in remission |
| C8600 | Extranodal NK/T-cell lymphoma, nasal type not having achieved remission |
| C8601 | Extranodal NK/T-cell lymphoma, nasal type, in remission |
| C8610 | Hepatosplenic T-cell lymphoma not having achieved remission |
| C8611 | Hepatosplenic T-cell lymphoma, in remission |
| C8620 | Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission |
| C8621 | Enteropathy-type (intestinal) T-cell lymphoma, in remission |
| C8660 | Primary cutaneous CD30-positive T-cell proliferations not having achieved remission |
| C8661 | Primary cutaneous CD30-positive T-cell proliferations, in remission |
| C91A0 | Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91A1 | Mature B-cell leukemia Burkitt-type, in remission |
| C91A2 | Mature B-cell leukemia Burkitt-type, in relapse |
| C9220 | Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission |
| C9221 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C9222 | Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C9290 | Myeloid leukemia, unspecified, not having achieved remission |
| C9291 | Myeloid leukemia, unspecified in remission |
| C9292 | Myeloid leukemia, unspecified in relapse |
| C92Z0 | Other myeloid leukemia not having achieved remission |
| C92Z1 | Other myeloid leukemia, in remission |
| C92Z2 | Other myeloid leukemia, in relapse |
| C9310 | Chronic myelomonocytic leukemia not having achieved remission |
| C9311 | Chronic myelomonocytic leukemia, in remission |
| C9312 | Chronic myelomonocytic leukemia, in relapse |
| C9330 | Juvenile myelomonocytic leukemia, not having achieved remission |
| C9331 | Juvenile myelomonocytic leukemia, in remission |
| C9332 | Juvenile myelomonocytic leukemia, in relapse |
| C9390 | Monocytic leukemia, unspecified, not having achieved remission |
| C9391 | Monocytic leukemia, unspecified in remission |
| C9392 | Monocytic leukemia, unspecified in relapse |
| C93Z0 | Other monocytic leukemia, not having achieved remission |
| C93Z1 | Other monocytic leukemia, in remission |
| C93Z2 | Other monocytic leukemia, in relapse |
| C9430 | Mast cell leukemia not having achieved remission |
| C9431 | Mast cell leukemia, in remission |
| C9432 | Mast cell leukemia, in relapse |
| C9480 | Other specified leukemias not having achieved remission |
| C9481 | Other specified leukemias, in remission |
| C9482 | Other specified leukemias, in relapse |
Where these codes sat in the V22 model
The V28 recalibration renumbered and regrouped categories; this table shows which legacy V22 categories the same ICD-10 codes belonged to, which is the quickest way to reconcile a V22-era HCC gap list with the current model.
| V22 HCC | Codes |
|---|---|
| 10 | 142 |
| 9 | 90 |
| 11 | 1 |
Capturing and defending the category
A category counts for a payment year when a mapped diagnosis is documented at least once during the data collection year by an acceptable provider type at a face-to-face or audio-video encounter, and when the note shows the condition was monitored, evaluated, assessed or treated. Chronic conditions do not carry forward: a category that is not re-documented in the year drops out of the score, which is why annual wellness visits and problem-list reconciliation are where most recapture happens. Risk adjustment data validation audits sample enrollees and ask for the medical record behind each submitted category; an unsupported category is removed and, under the extrapolation rules, the error rate is applied across the contract. The QuickIntell risk adjustment product surfaces suspected and unsupported categories from the chart, and the HCC hub lists every V28 category with its factor and code count.
Frequently asked questions
Which ICD-10 codes map to HCC 20?
233 ICD-10-CM codes map to HCC 20 in the CMS PY2027 initial mapping, for example C153 Malignant neoplasm of upper third of esophagus; C154 Malignant neoplasm of middle third of esophagus; C155 Malignant neoplasm of lower third of esophagus; C158 Malignant neoplasm of overlapping sites of esophagus. The full list is on this page; a code counts only when it is documented at a face-to-face or video encounter in the data collection year and supported by the record.
How much does HCC 20 add to a risk score?
The V28 relative factor for HCC 20 is 1.136 for a community, non-dual, aged beneficiary, 1.166 for full-benefit dual aged, 0.978 for non-dual disabled and 0.672 for long-term institutional members. A factor of 1.000 equals the expected annual cost of an average beneficiary, so the category's share of the payment follows the plan's base rate for that segment.
Does HCC 20 count together with related categories?
No. Within a hierarchy only the most severe category is paid. HCC 20 is dropped when HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic) or HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid) or HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers) is also present, and it drops HCC 21, HCC 22, HCC 23 when it is present.
What has to be documented for HCC 20 to be valid?
The diagnosis must be recorded by an acceptable provider type during a face-to-face or audio-video encounter in the service year, with the note showing that the condition was monitored, evaluated, assessed or treated. Risk adjustment data validation audits recover payment for categories the record does not support, so the code on the claim and the assessment in the note must match.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.
- ICD-10-CM to CMS-HCC V28 mappings, payment year 2027 initialVersion PY2027 initial ICD-10-CM mappings (dates of service 2026) · effective 2027-01-01 · file 2027 Initial ICD-10-CM Mappings.csvSHA-256 9c260b06d0dd2806…
- CMS-HCC V28 model software: labels, hierarchies and relative factorsVersion CMS-HCC V28 software V2826.115.T2 (PY2027 initial) · effective 2027-01-01 · file C2824T2N.csvSHA-256 20f38d537493b41c…
Disclaimer
Relative factors and mappings are reproduced from the CMS risk adjustment model files as an operational reference. Payment depends on the plan's base rate, normalization, the coding intensity adjustment and the enrollee's segment. Not legal, clinical or billing advice.